300 likes | 395 Views
E URO pean network of transnational collaborative RTD projects in the field of NANOMED icine. What are the societal needs? - the challenge for Europe. Improve public health and welfare Ageing population Efficiency of current medical solutions
E N D
EUROpean network of transnational collaborative RTD projects in the field of NANOMEDicine www.euronanomed.net
What are the societal needs? - the challenge for Europe Improve public health and welfare • Ageing population • Efficiency of current medical solutions • Emergence of new disease and old diseases are back • Personalized medicine future directions www.euronanomed.net
The global challenge • Therapeutic solutions for only 1/3 known diseases (WHO) • Infections: HIV, TB, malaria, risk of pandemia • Need to increase capability and innovation of medical industry • Rapid and accurate diagnosis for early detection, even prevention • Novel, more efficient therapies with less side effects www.euronanomed.net
Nano from research to patient and industry Nanomedicine: the application of nanotechnology to achieve breakthroughs in healthcare Bridging the gap Foto: kaibara87/www.flickr.com www.euronanomed.net
ES G UK F DE CP With ERA-Net CP CP CP Prog F Prog G Prog UK Prog ES Prog DE CP … Without ERA-Net Common transnational dedicated CP Principle of theERA-net scheme (CP: Call for projects) € : EC supports the coordination costs. Each national programme supports their national partners within the selected projects www.euronanomed.net
EuroNanoMed achieves a critical mass of actors Who we are • 24 partners (agencies and ministries) from 18 countries/regions • Aligning parts of their national / regional funding programs according to the FP7 ERA-Net scheme • Started January 2009 for 3 years • EU funding for coordination (FP7) • 3 common joint calls for proposals 2009, 2010, 2011 Joint trans-national RTD projects in nanomedicine www.euronanomed.net
EuroNanoMed: an asset to bridge the gap Aims of the Calls • Develop innovative diagnostic and therapeutic solutions for the patient • Solving unmet medical needs • Enhancing the competitiveness of the European health industry • Maturation of the Nanomedicine field in Europe • Cross-border collaboration between the best researchers / teams in Nanomedicine, bringing together teams from • academic / public research • clinical / public health • industry www.euronanomed.net
Why now? What’s the urgency? • Health industry: a key for future growth • European countries invest substantially in nano industry and basic nano research • Nano technologies: a promising field for innovation and patient application Despite these efforts, Europe is lagging behind the US in an increasing competition : Europe needs to act now! www.euronanomed.net
Expected outcome • To move innovation from knowledge to industrial technology and health care applications • Opening the national programmes to support transnational RTD partnerships Long term vision: formula for an European-wide integrated programme with a coordinated funding www.euronanomed.net
Contacts • Coordinator and Executive Board Chair Dr. Virginie Sivan Commissariat à l’Energie Atomique (CEA) Virginie.sivan@cea.fr (+33) 1 69 08 87 99 • Network Steering Committee chair Dr. Olaf Rotthaus VDI Technologiezentrum GmbH (VDI) rotthaus@vdi.de (+49) 211 6214-233 www.euronanomed.net
Joint Transnational Calls for proposals : RESULTS • JTC-1: 2009 • JTC-2: 2010 www.euronanomed.net
RESULTS JTC-1 and JTC-2 JTC-1 2009 JTC-2 2010 www.euronanomed.net
Submitted projectsPartners distribution /country-region JTC-1 JTC-2 www.euronanomed.net
Submitted projects Category of partners JTC-1 2009 JTC-22010 Consortium composition Translational Collaboration www.euronanomed.net
Submitted projects Main scientific subfields JTC-1 2009 JTC-22010 www.euronanomed.net
Funded projectsPartners /country-region JTC-1 2009 JTC-22010 Total 46 Total 40 www.euronanomed.net
Funded projectsMain scientific subfields JTC-1 2009 JTC-22010 -gene therapy -Immunotherapy -photodynamic therapy -anti-cancer therapies -development of vaccines -regeneration of the nervous system and sensory organs. -cancer -inflammatory diseases -bone regeneration -muscular dystrophy -immunology -vaccines www.euronanomed.net
EuroNanoMed: open Call 3rd Joint Transnational Call for Proposals • 14 Countries / Regions Deadline: April 15th 2011 www.euronanomed.net
Participating Funding Organisations • Industry, Innovation, Trade and Tourism Department, Basque Government • The French National Research Agency (ANR) • VDI Technologiezentrum GmbH • The Icelandic Centre for Research (RANNIS) • The Chief Scientist Office, The Ministry of Health (CSO-MOH) • The Latvian Academy of Sciences (LAS) • Science Council of Lithuania (LSC) • National Centre for Research and Development (NCBiR) • Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI) • Instituto de Salud Carlos III (ISCIII) • Swiss National Science Foundation (SNSF) • The Scientific and Technological Research Council of Turkey (TUBITAK) • Project Unit research and innovation, Veneto Region • Ministry of the Walloon Region: Operational General Directorate for Economy, Employment,and Research (DGOEER) BASQUE REGION (SPAIN) FRANCE GERMANY ICELAND ISRAEL LATVIA LITHUANIA POLAND ROMANIA SPAIN SWITZERLAND TURKEY VENETO REGION (ITALY) WALLOON REGION (BELGIUM) www.euronanomed.net
Topics / Funding Topics • Diagnostics Targeted • drug delivery • Regenerative medicine Funding • Indicative total funding 11 M € • Duration: Up to 3 years • Every project partner will receive the funding from his national agency www.euronanomed.net
Eligibility criteria Consortium composition • 3 – 7 partners per consortium • Partners from at least 3 different countries • (with a majority of partners from funding member states/regions participating in the call) • Partners from at least two of the three categories • academic / public research • clinical / public health • industry • Eligibility of partners also depends on national regulation in their country or region! • Read carefully the“Country specific information for applicants” • Contact your national agency (contact person) www.euronanomed.net
Time lines • Call open since: January 14th 2011 • Deadline for proposals: April 15th 2010, 17:00:00 (Brussels Time) • Funding Decision: October 2011 • Start of Projects: January 2012 www.euronanomed.net
How to apply? 1. EuroNanoMed Website www.euronanomed.net www.euronanomed.net
How to apply? 2. Download Call Text , Guidelines for applicants and Country specific Information www.euronanomed.net
How to apply? 3. Contact your national contact point (list in the Country-region specific information) 4. Download and fill in the Proposal Template www.euronanomed.net
How to apply? 5. Online Submission using the EuroNanoMed Submission Tool www.nanomedsubmission.net www.euronanomed.net
How to apply? • Register by clicking on the link ”to register” on the homepage http://www.euronanomed.net/*; you will receive an email confirming your registration • Accede to the EuroNanoMed Electronic Submission System* (Use the username and password you chose for the registration) fill in all the details and upload your proposal document (pdf format only), which you have previously filled in on your computer (see The Proposal Template)*. • Submit your proposal : Click on “submit proposal” to confirm your submission; you will receive an email confirming its receipt. Modify your data at any time until the submission deadline. It is strongly recommended to transfer the final version in proper time before this date www.euronanomed.net
Expression of Interest Tool • Present your project ideas • Find partners www.nanomedsubmission.net www.euronanomed.net
For more information • EuroNanoMed Call Office Veneto Nanotech s.c.p.a. Via San Crispino, 10635129 Padova – Italy : +39 049 7705520 e-mail: calloffice@euronanomed.net • National / Regional Contact Points • www.euronanomed.net www.euronanomed.net
Together we are building Nanomedicine for the future! www.euronanomed.net